We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

82 hedge funds and large institutions have $70.9M invested in Genesis Healthcare, Inc. in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 4

113% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 15

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

57% more capital invested

Capital invested by funds: $45M → $70.9M (+$25.8M)

22% more funds holding

Funds holding: 6782 (+15)

Holders
82
Holders Change
+15
Holders Change %
+22.39%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
19
Increased
32
Reduced
15
Closed
4
Calls
$66K
Puts
Net Calls
+$66K
Net Calls Change
+$26K

GEN Hedge Fund Activity: Q2 2018 in Review

82 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2018, worth a combined $70.9M — up 57% from $45M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new GEN positions and 4 closed out — a net gain of 15 holders — while 32 added to existing stakes and 15 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.67M. The largest seller was Columbia Pacific Advisors, cutting an estimated $6.57M.

  • 82 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q2 2018, up from 67 in Q1 2018.
  • Funds reported $70.9M of Genesis Healthcare, Inc. stock for Q2 2018, up 57% quarter-over-quarter.
  • 19 funds opened new Genesis Healthcare, Inc. positions in Q2 2018 and 4 closed out, a net change of +15 holders.
  • The largest Genesis Healthcare, Inc. buyer in Q2 2018 was Renaissance Technologies, an estimated $1.67M added.
  • The largest Genesis Healthcare, Inc. seller in Q2 2018 was Columbia Pacific Advisors, an estimated $6.57M sold.

Based on aggregated 13F filings for Q2 2018.